Halbert Hargrove Global Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-26
Closed -$1.1K – 648
2026
Q2
$1.1K Buy
+26
New +$1.16K ﹤0.01% 434
2025
Q2
– Sell
-152
Closed -$8.43K – 601
2025
Q1
$8.43K Buy
+152
New +$8.23K ﹤0.01% 267

Other funds holding SNY

Halbert Hargrove Global Advisors's SNY Position: Q3 2026 in Review

Halbert Hargrove Global Advisors sold out of Sanofi (SNY) in Q3 2026, closing a stake of 26 shares — an estimated $1.1K sold.

Halbert Hargrove Global Advisors first reported a position in SNY in Q1 2025 and held it in 2 quarters. The position peaked at $8.43K in Q1 2025. 688 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Halbert Hargrove Global Advisors reported no remaining Sanofi position as of Q3 2026 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 26 Sanofi shares in Q3 2026, an estimated $1.1K.
  • Halbert Hargrove Global Advisors first reported a position in Sanofi in Q1 2025 and held it in 2 quarters.
  • Halbert Hargrove Global Advisors's Sanofi position peaked at $8.43K in Q1 2025.
  • 688 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.